glp 1 approved for mash 🔴We now have two FDA-approved drugs MASLD/MASH: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) side-by-side comparison, courtesy of @rabataller #MASLD #MASH #FattyLiver @_ILTS_ @EASLedu @AASLDtweets @novonordisk Emerging Role of GLP-1 Receptor

The nitric oxide synthase inhibitor, L-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice

Fibroblast growth factor receptor signaling in metabolic dysfunction-associated fatty liver disease: Pathogenesis and therapeutic targets

This suggests that GLP-1R agonism can reduce ethanol-mediated hepatotoxicity despite continued ethanol consumption and elevate blood alcohol levels

Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease

He's back on compounded tirzepatide from his local pharmacy.

[5] The methylation cycle hypothesis states that many if not all of the symptoms of CFS are caused by errors in the genes that regulate or have a strong impact on one-carbon metabolism, such as MTHFR, CBS, DHPR, MTRR, or MAO-A